Entity type
Company
CIK 0001618921. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Entity type
Company
Total filings
159
Latest filing
28 Aug 2025
Industry
Retail Drug Stores And Proprietary Stores
Filing-backed research brief
Latest signal: 13F-HR for Q2 2025. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
$2.24B
1 holdings for Q2 2025
Open portfolioLargest parsed holding
COR
$2.24B reported value
Open holding13D/G large stake
COR
09 Jun 2025 · 5% ownership
Open 13D/GInsider / owner context
COR
06 Feb 2025 · $3.07B
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
4 filed on 28 Aug 2025 for CIK 0001618921.
Latest 13F value
$2.24B
Reported market value from the latest parsed Form 13F portfolio.
Owner filing value
$3.6B
Estimated from parsed Forms 3/4/5 when the filing discloses enough data.
Leading 13F symbols
COR
Largest visible symbols from the latest parsed Form 13F information table.
Top parsed positions across ownership filing types.
Top symbols from the latest parsed Form 13F information table.
Large-stake holdings reported on parsed Schedule 13D filings.
Large-stake holdings reported on parsed Schedule 13G filings.
Filer intelligence
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Counts show available parsed rows, not one combined ownership total.
Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.
Top 5 concentration
100%
Share of latest parsed 13F value represented by the visible holdings below.
Top 5 reported value
$2.24B
Compared with $2.24B total 13F value.
Top 5 net change
-$1.07B
Position-value change inside the visible top holdings only.
A simple visual split of the latest parsed 13F portfolio.
Largest trim: COR
COR
09 Jun 2025 · Common Stock, par value $0.01 per share
BTSG
07 May 2025 · Common Stock, par value $0.01 per share
COR
06 Feb 2025 · 10% owner
OPCH
01 Mar 2023 · 10% owner
BTSG
18 Feb 2025
Latest update
Latest 13F period: Q2 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
15 Aug 2025
Page type
Filer profile
Latest period
Q2 2025
Institutional portfolio context was refreshed from a 13F filing filed on 15 Aug 2025.
Benchmark Context
Walgreens Boots Alliance, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest 13F period: Q2 2025. That gives you a fresh baseline before you compare this company with peers.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
Observed form types
Industry context: Retail Drug Stores And Proprietary Stores.
Showing the latest 12 of 159 SEC filings for Walgreens Boots Alliance, Inc..